BackForte Biosciences Overview

Forte Biosciences Common Stock

Track Forte Biosciences's common stock ($21K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$21000.00
↑ 75.00% YoYΔ $9000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Forte Biosciences Common Stock History

Loading

Forte Biosciences vs. peers: Common Stock Comparison

Loading

Forte Biosciences Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Forte Biosciences (FBRX) FAQ

As of the most recent data (June 2026), FBRX shows a common stock of $21K. That compares with $12K in the prior-year period — up 75.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FBRX's common stock is now $21K (was $12K) — a 75.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Forte Biosciences is outperforming or lagging.

Tracking FBRX's common stock over time shows whether Forte Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $21K That compares with $12K in the prior-year period — up 75.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Forte Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $21K) with ownership activity and broader fundamentals.

Forte Biosciences's common stock is $21K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.